Abstract:In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for the detection and assessment of cognitive decline in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Neurophysiological biomarkers of AD derived from EEG and FDG-PET, once characterized and validated, would expand the set of existing diagnostic molecular biomarkers of AD pathology with associated biomarkers of disease progression and neural dysfunction. Since symptoms of AD often begin to appear later in life, successful identification of EEG-based biomarkers must account for age-related neurophysiological changes that occur even in healthy individuals. To this end, we collected EEG data from individuals with AD (n = 26), MCI (n = 53), and cognitively normal healthy controls stratified by age into three groups: 18–40 (n = 129), 40–60 (n = 62) and 60–90 (= 55) years old. For each participant, we computed power spectral density at each channel and spectral coherence between pairs of channels. Compared to age matched controls, in the AD group, we found increases in both spectral power and coherence at the slower frequencies (Delta, Theta). A smaller but significant increase in power of slow frequencies was observed for the MCI group, localized to temporal areas. These effects on slow frequency spectral power opposed that of normal aging observed by a decrease in the power of slow frequencies in our control groups. The AD group showed a significant decrease in the spectral power and coherence in the Alpha band consistent with the same effect in normal aging. However, the MCI group did not show any significant change in the Alpha band. Overall, Theta to Alpha ratio (TAR) provided the largest and most significant differences between the AD group and controls. However, differences in the MCI group remained small and localized. We proposed a novel method to quantify these small differences between Theta and Alpha bands’ power using empirically derived distributions of spectral power across the time domain as opposed to averaging power across time. We defined Power Distribution Distance Measure (PDDM) as a distance measure between probability distribution functions (pdf) of Theta and Alpha power. Compared to average TAR, using PDDF enhanced the statistical significance, the effect size, and the spatial distribution of significant effects in the MCI group. We designed classifiers for differentiating individual MCI and AD participants from age-matched controls. The classification performance measured by the area under ROC curve after cross-validation were AUC = 0.85 and AUC = 0.6, for AD and MCI classifiers, respectively. Posterior probability of AD, TAR, and the proposed PDDM measure were all significantly correlated with MMSE score and neuropsychological tests in the AD group.

Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints

Spatiotemporal EEG Dynamics of Prospective Memory in Ageing and Mild Cognitive Impairment

The Changes of Central Auditory Processing Function and Its Electroencephalogram in Patients with Mild Cognitive Impairment and Early Alzheimer’s Disease

Event‐related potential signatures of episodic memory decline predicting progression to Alzheimer’s disease in asymptomatic at‐risk subjects: a longitudinal study.

Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials

The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic

The Importance of Subjective Cognitive Decline Recognition and the Potential of Molecular and Neurophysiological Biomarkers—A Systematic Review

Altered auditory processes pattern predicts cognitive decline in older adults: different modalities with aging

Features of Event-Related Potentials During Retrieval of Episodic Memory in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease

P300 Latency with Memory Performance: A Promising Biomarker for Preclinical Stages of Alzheimer's Disease

Subjective Memory Complaints in Preclinical Autosomal Dominant Alzheimer Disease

Event-Related Potential Markers of Subjective Cognitive Decline and Mild Cognitive Impairment during a sustained visuo-attentive task

Diagnostic value of event-related potentials in Alzheimer's disease and mild cognitive impairment.

Diagnostic Value of Event-Related Evoked Potentials N200 and P300 Subcomponents in Early Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment

Prefrontal intra-individual ERP variability and its asymmetry: exploring its biomarker potential in mild cognitive impairment

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment

Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology

The association between AD biomarkers and neuropsychiatric symptoms in subjective cognitive decline; the SCIENCe project

Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis

Exploring Potential Electrophysiological Biomarkers in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.

Electroencephalogram-based objective assessment of cognitive function level associated with age-related hearing loss